Biomarker Identification May Lead to New Noninvasive Test for Colorectal Cancer Detection, Yonsei University College of Medicine and Genomictree Study

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The average 5-year survival for colorectal cancer (CRC) is less than 10% if metastasis occurs, but can reach 90% if detected early. A new non-invasive test has been developed that measures methylation of the SDC2 gene in tissues and blood sera. This test detected 87% of all stages of colorectal cancer cases (sensitivity) without significant difference between early and advanced stages, while correctly identifying 95% of disease-free patients (specificity). The results are published in the July issue of The Journal of Molecular Diagnostics.

Hey, check out all the engineering jobs. Post your resume today!

MORE ON THIS TOPIC